Ozanimod Maintenance Therapy After Cyclosporine Induction in Acute Severe Ulcerative Colitis

被引：10

作者：

Cohen, Nathaniel A. ^{[1
]}

Dalal, Sushila R. ^{[1
]}

Choi, David ^{[1
]}

Rubin, David T. ^{[1
]}

机构：

[1] Univ Chicago Med, Inflammatory Bowel Dis Ctr, Chicago, IL 60637 USA

来源：

ACG CASE REPORTS JOURNAL | 2022年 / 9卷 / 07期

关键词：

INFLIXIMAB;

D O I：

10.14309/crj.0000000000000832

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Ozanimod has recently received US Food and Drug Administration approval for moderate-to-severe ulcerative colitis. Treatment of acute severe colitis remains a clinical challenge, and although many patients respond to cyclosporine therapy, there remains a relative paucity of maintenance options. This case report describes the first reported, successful use of ozanimod after hospitalization for acute severe ulcerative colitis and in tandem with cyclosporine. Although a longer follow-up is required, this report shows the feasibility of ozanimod in this clinical setting.

引用

页数：4

共 9 条

[1] Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis [J].

Brandse, Johannan F. ;

van den Brink, Gijs R. ;

Wildenberg, Manon E. ;

van der Kleij, Desiree ;

Rispens, Theo ;

Jansen, Jeroen M. ;

Mathot, Ron A. ;

Ponsioen, Cyriel Y. ;

Lowenberg, Mark ;

D'Haens, Geert R. A. M. .

GASTROENTEROLOGY, 2015, 149 (02) :350-+

[2] FTY720: Sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function [J].

Brinkmann, V ;

Cyster, JG ;

Hla, T .

AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (07) :1019-1025

[3] Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease [J].

Christensen, Britt ;

Gibson, Peter R. ;

Micic, Dejan ;

Colman, Ruben J. ;

Goeppinger, Sarah R. ;

Kassim, Olufemi ;

Yarur, Andres ;

Weber, Christopher R. ;

Cohen, Russell D. ;

Rubin, David T. .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (03) :486-493

[4] The pattern and outcome of acute severe colitis [J].

Dinesen, Lotte C. ;

Walsh, Alissa J. ;

Protic, Marijana Nedeljkovic ;

Heap, Graham ;

Cummings, Fraser ;

Warren, Bryan F. ;

George, Bruce ;

Mortensen, Neil J. M. ;

Travis, Simon P. L. .

JOURNAL OF CROHNS & COLITIS, 2010, 4 (04) :431-437

[5] C-reactive protein is an indicator of serum infliximab level in predicting loss of response in patients with Crohn's disease [J].

Hibi, Toshifumi ;

Sakuraba, Atsushi ;

Watanabe, Mamoru ;

Motoya, Satoshi ;

Ito, Hiroaki ;

Sato, Noriko ;

Yoshinari, Toru ;

Motegi, Kenta ;

Kinouchi, Yoshitaka ;

Takazoe, Masakazu ;

Suzuki, Yasuo ;

Matsumoto, Takayuki ;

Kawakami, Kazuhiko ;

Matsumoto, Takayuki ;

Hirata, Ichiro ;

Tanaka, Shinji ;

Ashida, Toshifumi ;

Matsui, Toshiyuki .

JOURNAL OF GASTROENTEROLOGY, 2014, 49 (02) :254-262

[6] High C-reactive protein in Crohn's disease patients predicts nonresponse to infliximab treatment [J].

Magro, Fernando ;

Rodrigues-Pinto, Eduardo ;

Santos-Antunes, Joao ;

Vilas-Boas, Filipe ;

Lopes, Susana ;

Nunes, Amadeu ;

Camila-Dias, Claudia ;

Macedo, Guilherme .

JOURNAL OF CROHNS & COLITIS, 2014, 8 (02) :129-136

[7] Efficacy and safety of induction therapy with calcineurin inhibitors followed by vedolizumab maintenance in 71 patients with severe steroid-refractory ulcerative colitis [J].

Ollrch, Jacob E. ;

Dwadasi, Sujaata ;

Rai, Victoria ;

Peleg, Noam ;

Normatov, Inessa ;

Israel, Amanda ;

Sossenheimer, Philip H. ;

Christensen, Britt ;

Pekow, Joel ;

Dalal, Sushila R. ;

Sakuraba, Atsushi ;

Cohen, Russell D. ;

Rubin, David T. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (06) :637-643

[8] Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis [J].

Sandborn, William J. ;

Feagan, Brian G. ;

D'Haens, Geert ;

Wolf, Douglas C. ;

Jovanovic, Igor ;

Hanauer, Stephen B. ;

Ghosh, Subrata ;

Petersen, AnnKatrin ;

Hua, Steven Y. ;

Lee, Ji Hwan ;

Charles, Lorna ;

Chitkara, Denesh ;

Usiskin, Keith ;

Colombel, Jean-Frederic ;

Laine, Loren ;

Danese, Silvio .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (14) :1280-1291

[9] Multiple-Dose Pharmacokinetics of Ozanimod and its Major Active Metabolites and the Pharmacodynamic and Pharmacokinetic Interactions with Pseudoephedrine, a Sympathomimetic Agent, in Healthy Subjects [J].

Tran, Jonathan Q. ;

Zhang, Peijin ;

Walker, Susan ;

Ghosh, Atalanta ;

Syto, Mary ;

Wang, Xiaomin ;

Harris, Sarah ;

Palmisano, Maria .

ADVANCES IN THERAPY, 2020, 37 (12) :4944-4958

← 1 →